首页> 外国专利> METHOD FOR PREDICTING COURSE OF REPARATIVE PROCESSES IN OUTFLOW TRACTS OF INTRAOCULAR FLUID IN PATIENTS WITH OPEN-ANGLE GLAUCOMA AFTER NON-PENETRATING DEEP SCLERECTOMY

METHOD FOR PREDICTING COURSE OF REPARATIVE PROCESSES IN OUTFLOW TRACTS OF INTRAOCULAR FLUID IN PATIENTS WITH OPEN-ANGLE GLAUCOMA AFTER NON-PENETRATING DEEP SCLERECTOMY

机译:在非渗透深氧化术后,在开放角度荧光眼患者患者流出症中预测过程中的复发过程中的方法

摘要

FIELD: medicine. ;SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be used to predict the course of reparative processes in the outflow tracts of intraocular fluid in patients with open-angle glaucoma after non-penetrating deep sclerectomy. The dynamics of the concentration of TGF-β and MMP-9 in the lacrimal fluid of patients in the postoperative period is assessed. The dynamics of the concentration of TGF-β and MMP-9 in the lacrimal fluid of patients is determined before surgery. The dynamics of the concentration of TGF-β and MMP-9 in the lacrimal fluid of patients is also determined 14 days after non-penetrating deep sclerectomy. In the case of a moderate increase in TGF-β of a tear, equal to 280-350 pg / ml, and the MMP-9 content in a tear, equal to 83-174 ng/ml, a favorable course of reparative processes in the outflow tracts of the intraocular fluid is predicted, which does not require correction of the anti-inflammatory therapy regimen. When TGF-β is less than or equal to 189 pg / ml, and MMP-9 in tears is equal to 4.25-82.5 ng/ml, a moderately favorable course of reparative processes is predicted, requiring either strengthening and prolongation of local instillation anti-inflammatory therapy, or performing the needling of the filtering bleb. With a significant increase in the concentration of TGF-β of a tear, equal to 600-750 pg / ml, and the level of MMP-9 of a tear up to 2.6 ng/ml, the course of reparative processes is considered conditionally unfavorable in terms of the hypotensive efficacy of antiglaucoma surgery and there is a need for active anti-inflammatory and anti-fibrotic therapy.;EFFECT: method enables the development of an algorithm for predicting the course of reparative processes in the outflow tracts of intraocular fluid in patients with open-angle glaucoma after non-penetrating deep sclerectomy and further planning of therapeutic measures aimed at limiting the fibrous transformation of the newly created outflow tracts, by determining the dynamics of the concentration of TGF-β and MMP-9 in the lacrimal fluid of patients before surgery, as well as 14 days after non-penetrating deep sclerectomy.;1 cl, 3 ex
机译:领域:医学。 ;物质:发明涉及药物,即眼科,并且可用于预测在非渗透深氧化术后开孔荧光眼的眼内液中的患者的流出过程中的复发过程的过程。评估了术后期间患者泪液中TGF-β和MMP-9的浓度的动态。在手术前确定患者泪流体中TGF-β和MMP-9的浓度的动态。在非渗透深氧化术后14天内也测定TGF-β和MMP-9中TGF-β和MMP-9的动态。在撕裂的TGF-β中等增加的情况下,等于280-350pg / ml,以及撕裂的MMP-9含量,等于83-174ng / ml,是一种有利的重新处理过程预测人工液的流出束,这不需要纠正抗炎治疗方案。当TGF-β小于或等于189pg / ml时,泪液中的MMP-9等于4.25-82.5ng / ml时,预测了适度良好的检测过程,需要加强和延长局部滴注抗-INLINOMORY疗法,或执行过滤烧伤的针刺。撕裂的TGF-β的浓度显着增加,等于600-750pg / ml,并且撕裂的MMP-9水平高达2.6ng / ml,经过可条件性不利的过程就抗原瘤手术的低血压疗效而有必要激活抗炎和抗纤维化疗法。;效果:方法能够开发一种用于预测人眼内流体流出的废弃过程中的算法非穿透深氧化术后患者的患者,并进一步规划旨在限制新产生的流出束的纤维转化,通过确定泪液中TGF-β和MMP-9浓度的动态手术前的患者,在非渗透深氧化术后14天。; 1 CL,3 EX

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号